Compounds and compositions for targeting brain injuries and methods of use thereof
Compositions are disclosed which include a CAQK peptide linked or conjugated to a cargo composition, where the peptide selectively homes the composition to a site of nervous system injury in a subject.
1. A composition comprising a peptide linked or conjugated to a cargo composition, wherein the peptide consists of the amino acid sequence CAQK (SEQ ID NO:4).
2. The composition of claim 1 , wherein the peptide and the cargo composition are covalently coupled.
3. The composition of claim 1 , wherein the peptide selectively homes the cargo composition to a site of acute brain injury in a subject.
4. The composition of claim 1 , wherein the peptide selectively homes the cargo composition to a site of glial scar formation.
5. The composition of claim 1 , wherein the peptide specifically binds to one or more of versican, tenascin-R, and Hapln.
6. The composition of claim 1 , wherein the cargo composition comprises cargo molecules.
7. The composition of claim 6 , wherein the cargo molecules independently comprise a therapeutic agent, a labeling agent, a contrasting agent or an imaging agent.
8. The composition of claim 7 , wherein the therapeutic agent is a polypeptide or a nucleic acid molecule.
9. The composition of claim 1 , wherein the cargo composition further comprises a surface molecule.
10. The composition of claim 9 , wherein the surface molecule is selected from the group consisting of a nanoparticle, a nanoworm, an iron oxide nanoworm, an iron oxide nanoparticle, an albumin nanoparticle, a liposome, a micelle, a phospholipid, a polymer, a microparticle, a bead, a virus, a phage, a viral particle, a phage particle, a viral capsid, a phage capsid, a virus-like particle, or a fluorocarbon microbubble.
11. The composition of claim 1 , wherein the cargo composition comprises a functional nucleic acid encapsulated within a nanoparticle.